Régis Rieu

Dr. Régis Rieu


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2020 in Cardiovascular Engineering and Technology
Verified
Journal Article
Closed access
PDF file
CPChloé Papolla
Chloé Papolla
ADAhmed Darwish
Ahmed Darwish
LKLyes Kadem
Lyes Kadem
RRRégis Rieu
Régis Rieu

7 April 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
KDKatell Delanoë
Katell Delanoë
ESErwan Salaun
Erwan Salaun
RRRégis Rieu
Régis Rieu
CCCote Cote
Cote Cote
PPPhilippe Pibarot
Philippe Pibarot
VSViktória Stanová
Viktória Stanová
Mitral valve regurgitation is among the most prevalent valvular heart diseases and increases with age. Percutaneous therapy has emerged for the management of mitral regurgitation in high surgical risk patients. However, the long-term consequences of these interventions are still not fully understood due to their novelty and the difficulty of developing a strategy specific to the patient’s anatomy and/or pathology. To optimize these outcomes, an in vitro patient-specific approach could provide important insights for the most suitable strategy to use according to the patient profile. To ensure the reliability of this in vitro approach, the aim of this study was to reproduce the physiological behavior of the healthy native mitral valve for future applications. To do so, different silicon combinations reproducing the physiological anatomy of a healthy mitral valve were developed and tested under physiological hemodynamic conditions in a cardiac simulator. The hemodynamic and biomechanical behaviors of each mitral valve model were analyzed and compared to the physiological values provided in the literature. This study identified EcoFlex 00-50 and DragonSkin 10 (Smooth-On Inc., Easton, PA, USA) as the optimal silicon combination resulting in physiological strain values and hemodynamic parameters. These findings could be useful for future patient-specific applications, helping in the optimization of percutaneous mitral valve therapy.

26 September 2012 in Computer Methods in Biomechanics and Biomedical Engineering
Verified
Journal Article
Closed access
MEM. Evin
M. Evin
CGC. Guivier-Curien
C. Guivier-Curien
DTD. Tanne
D. Tanne
PPP. Pibarot
P. Pibarot
RRRégis Rieu
Régis Rieu

25 February 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
KDKatell Delanoë
Katell Delanoë
ESErwan Salaun
Erwan Salaun
RRRégis Rieu
Régis Rieu
CCCote Cote
Cote Cote
PPPhilippe Pibarot
Philippe Pibarot
VSViktória Stanová
Viktória Stanová
Mitral valve regurgitation is among the most prevalent valvular heart diseases and increases with age. Percutaneous therapy has emerged for the management of mitral regurgitation in high surgical risk patients. However, long-term consequences of these interventions are still not fully understood due to their novelty and the difficulty to develop a strategy specific to the patient’s anatomy and/or pathology. To optimize these outcomes, an in vitro patient-specific approach could provide important insights for the most suitable strategy to use according to the patient profile. To ensure reliability of this in vitro approach, aim of this study was to reproduce the physiological behavior of the healthy native mitral valve for future applications. To do so, different silicon combinations reproducing physiological anatomy of healthy mitral valve were developed and tested under physiological hemodynamic conditions in a cardiac simulator. The hemodynamic and biomechanical behaviors of each mitral valve model were analyzed and compared to the physiological values provided in the literature. This study identified EcoFlex 00-50 and DragonSkin 10 (Smooth-On Inc, USA) as the optimal silicon combination resulting in physiological strain values and hemodynamic parameters. These findings could be useful for future patient-specific applications, helping in the optimization of percutaneous mitral valve therapy.

1 July 2013 in Computer Methods in Biomechanics and Biomedical Engineering
Verified
Journal Article
Closed access
MEM. Evin
M. Evin
CGC. Guivier-Curien
C. Guivier-Curien
AZA.S. Zenses
A.S. Zenses
RRRégis Rieu
Régis Rieu